Department of General Surgery, Darlington Memorial Hospital, Darlington, UK.
Br J Hosp Med (Lond). 2021 Apr 2;82(4):1-9. doi: 10.12968/hmed.2020.0577. Epub 2021 Apr 21.
Necrotising fasciitis is a severe, life-threatening and rapidly progressive soft tissue infection that often requires aggressive surgical management, with an estimated incidence of about 0.24-0.40 per 100 000 in the UK. Necrotising fasciitis can be classified based on its microbiology or the anatomy or body region affected. Initial signs of necrotising fasciitis can be minimal and non-specific but a patient often presents with pain out of proportion to clinical signs on examination, as well as erythema and oedema, in addition to systemic symptoms associated with sepsis. Diagnosis is often based on high clinical suspicion with biochemical and clinical imaging used as adjuncts. To aid with early diagnosis of necrotising fasciitis, a scoring system known as the Laboratory Risk Indicator for necrotising fasciitis was developed which has a positive predictive value of 92%. Once diagnosed, appropriate resuscitation and antibiotics, along with prompt and aggressive surgical debridement, is the mainstay of treatment.
坏死性筋膜炎是一种严重的、危及生命的、迅速进展的软组织感染,通常需要积极的手术治疗,在英国的发病率约为每 100000 人 0.24-0.40 例。坏死性筋膜炎可以根据其微生物学、解剖结构或受影响的身体部位进行分类。坏死性筋膜炎的最初迹象可能很少且不特异,但患者常表现为疼痛与临床检查所见不成比例,此外还伴有红斑和水肿,以及与败血症相关的全身症状。诊断通常基于高度临床怀疑,生化和临床影像学检查作为辅助手段。为了帮助早期诊断坏死性筋膜炎,开发了一种称为坏死性筋膜炎实验室风险指标的评分系统,其阳性预测值为 92%。一旦诊断明确,适当的复苏和抗生素治疗,以及及时和积极的手术清创,是治疗的主要方法。